Voyager Technologies
Prezzo: 3.50Società e modello di business
Voyager Technologies operates in the healthcare sector, focusing on developing innovative medical technologies and solutions. Its core products include diagnostic tools and therapeutic devices aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers. Recent financial performance indicates significant challenges, with a notable decline in revenue quarter-over-quarter.
Profilo di investimento
The investment profile of Voyager Technologies suggests it may be more aligned with value investors due to its current low stock price relative to potential future earnings. However, the high risk associated with its financial performance and market volatility indicates caution is warranted. The stock may not provide immediate returns, making it less suitable for growth or dividend-focused investors.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- -1.98 Rischio
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -83.1% ↓
- Sorpresa EPS
- 13.0% meglio del previsto
- Volatilità 20g
- 3.9% stabile
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-08 15:25 | — | Vendi | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-08 05:38 | Vendi | Mantieni | Компания показывает умеренный рост выручки, но отрицательный EPS и высокая волатильность цен указывают на значительные риски. Рекомендуется удерживать акции до получения более ясных сигналов о стабильности. |
| 2026-05-01 02:59 | Mantieni | Vendi | Компания показывает негативную динамику на длительном горизонте, однако недавний рост выручки может свидетельствовать о потенциальном улучшении. Рекомендуется удерживать акции до получения более ясных сигналов о восстано |
Ancora nulla